gradient circle (purple) gradient circle (green)

Food, Drug & Cosmetic Law Section 2024 Spring Meeting

Food, Drug & Cosmetic Law Section 2024 Spring Meeting


What will the healthcare/life science legal landscape look like in 2024?

With the rise of personalized medicine, digital therapeutics and AI, we can expect new laws and regulations governing these healthcare innovations. The FDA and the FTC have expanded their oversight of cosmetics and health claims, respectively. We await the Supreme Court opinion on who has standing to challenge FDA drug approvals, and the possible avalanche of challenges if the appellate court definition is affirmed. 


Hence the need to examine how these changes will impact the healthcare and life science legal community. 


This year’s Spring Meeting will focus on the following:


-The Modernization of Cosmetic Regulations Act of 2022 and its impact on the industry.


-The implementation of FTCs healthcare product compliance guidelines.


-The next regulatory frontier for telemedicine post Covid-19.


-Use of AI in drug research and predictive personalized patient care, and the legal issues around these uses.


-Will the mifepristone decision redefine standing to challenge FDA drug approvals?


Start Date:
  • April 11, 2024
Start Time:
  • 8:00 AM
End Time:
  • 1:00 PM
Areas Of Professional Practice Credit(s):
  • 5.0
Total Credit(s):
  • 5.0
  • Virtual Participation
  • Webinar
Product Code:
  • 0NU31
Section Member Price: $100.00
NYSBA Member Price: $125.00 Join (or renew) for special member pricing
Non-Member Price: $175.00
Sponsoring Committee Group
  • Committee on Continuing Legal Education
  • Food, Drug & Cosmetic Law Section